Impact of PDCA cycle-driven nutritional support on serum biomarkers and quality of life in nasopharyngeal carcinoma patients undergoing radiotherapy
Authors:
Open Access
- 1 January 2025
- journal article
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Journal of Medical Biochemistry
- Vol. 44 (8) , 1693-1702
Abstract
Background: This study aimed to assess the effectiveness of nutritional support guided by the PDCA (Plan-Do-Check-Act) cycle management model in nasopharyngeal carcinoma (NPC) patients undergoing radiotherapy. Methods: A total of 100 NPC patients between December 2021 and October 2023 were randomly assigned to two groups: an observation group (OG, n = 50) and a control group (CG, n = 50). The CG received routine nutritional support, while the OG received nutritional support based on the PDCA cycle. Key outcomes included blood nutritional biomarkers, quality of life (QoL), incidence of adverse reactions (ARs), and clinical efficacy. Results: Post-treatment analysis showed that the OG had a significantly higher total effective rate (72%) compared to the CG (38%) (P< 0.05). The OG also showed higher albumin, prealbumin, and total protein levels and lower CRP levels after treatment. The OG significantly improved cognitive, role, social, physical, and emotional functioning (P< 0.05). The AR rate was considerably lower in the OG (20%) compared to the CG (36%) (P< 0.05). Conclusions: These results suggest that PDCA cycle-based nutritional support enhances clinical efficacy and QoL, reduces nutritional risks and adverse reactions and improves overall safety in NPC patients undergoing radiotherapy. Serum markers like serum iron, ferritin, prealbumin, and CRP effectively monitored the impact of nutritional interventions on patients' nutritional and inflammatory status.Keywords
This publication has 26 references indexed in Scilit:
- Effect of Nutritional Intervention on the Management of Radiotherapy and Chemotherapy for Nasopharyngeal CarcinomaNutrition and Cancer, 2023
- The effect of material assignment in nasal cavity on dose calculation for nasopharyngeal carcinoma (NPC) using Acuros XBJournal of Applied Clinical Medical Physics, 2022
- Clinical Characteristics, Classification, and Management of Adult Nasopharyngolaryngeal HemangiomaThe Laryngoscope, 2021
- Detection of hypopharyngeal cancer (Tis, T1 and T2) by ENT physicians vs gastrointestinal endoscopistsAuris Nasus Larynx, 2020
- Olfactory and gustatory functions after free flap reconstruction and radiotherapy for oral and pharyngeal cancer: a prospective follow-up studyEuropean Archives of Oto-Rhino-Laryngology, 2018
- Clinical Outcomes Comparing Parenteral and Nasogastric Tube Nutrition After Laryngeal and Pharyngeal Cancer SurgeryDysphagia, 2009
- Cigarette smoking, alcohol drinking, and oral and pharyngeal cancer mortality in JapanOral Diseases, 2007
- Formaldehyde and Glutaraldehyde and Nasal Cytotoxicity: Case Study Within the Context of the 2006 IPCS Human Framework for the Analysis of a Cancer Mode of Action for HumansCritical Reviews in Toxicology, 2006
- SHOULD NASAL-PARANASAL-ORONASOPHARYNGEAL LYMPHOMAS IN CHILDREN BE CLASSIFIED DIFFERENTLY FROM THE OTHER LOCALIZATIONS?Pediatric Hematology and Oncology, 2000
- Computed tomography in the management of head and neck cancerJournal of Computed Tomography, 1981